Hypoparathyroidism Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Hypoparathyroidism Market is segmented By Treatment (Hormone Replacement Therapy, Adjunctive Therapies), By Route of Administration (Oral, Parenteral)....
Hypoparathyroidism Market Size
Market Size in USD Mn
CAGR7.5%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 7.5% |
| Market Concentration | Medium |
| Major Players | Takeda Pharmaceutical Company Limited, Ascendis Pharma A/S, Amgen Inc., Entera Bio Ltd., Shire Plc and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Hypoparathyroidism Market Analysis
The hypoparathyroidism market is estimated to be valued at USD 731.1 Mn in 2024 and is expected to reach USD 1213.4 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. Advancements in drug research and development have enabled manufactures to explore novel treatment approaches for hypoparathyroidism. Growing access to healthcare infrastructure and services in developing regions is also supporting patients to seek and initiate early treatment.